• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by American Well Corporation

    5/15/25 4:21:34 PM ET
    $AMWL
    Real Estate
    Real Estate
    Get the next $AMWL alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 3)


    American Well Corp

    (Name of Issuer)


    Class A Common Stock

    (Title of Class of Securities)


    03044L105

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    03044L105


    1Names of Reporting Persons

    Caledonia (Private) Investments Pty Limited
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    AUSTRALIA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    810,268.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    810,268.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    810,268.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.80 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    CUSIP No.
    03044L105


    1Names of Reporting Persons

    Caledonia US, LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    810,268.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    810,268.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    810,268.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.80 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    American Well Corp
    (b)Address of issuer's principal executive offices:

    75 STATE STREET, 26TH FLOOR, Boston, MA, 02109
    Item 2. 
    (a)Name of person filing:

    Caledonia (Private) Investments Pty Limited Caledonia US, LP
    (b)Address or principal business office or, if none, residence:

    Caledonia (Private) Investments Pty Limited: Level 10, 131 Macquarie Street Sydney, NSW, 2000, Australia Caledonia US, LP 27th Floor, 1133 Avenue of the Americas New York, NY,10036
    (c)Citizenship:

    Caledonia (Private) Investments Pty Limited - Australia Caledonia US, LP - Delaware
    (d)Title of class of securities:

    Class A Common Stock
    (e)CUSIP No.:

    03044L105
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    810,268
    (b)Percent of class:

    5.80  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    810,268

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    810,268

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Caledonia (Private) Investments Pty Limited
     
    Signature:/s/ Matthew Moses
    Name/Title:Matthew Moses, General Counsel
    Date:05/15/2025
     
    Caledonia US, LP
     
    Signature:/s/ Matthew Moses
    Name/Title:Matthew Moses, General Counsel
    Date:05/15/2025
    Exhibit Information

    Exhibit I JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: May 15, 2025 Caledonia (Private) Investments Pty Limited By: /s/ Matthew Moses Matthew Moses, General Counsel Caledonia US, LP By: /s/ Matthew Moses Matthew Moses, General Counsel

    Get the next $AMWL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMWL

    DatePrice TargetRatingAnalyst
    1/13/2025$15.00Equal Weight → Overweight
    Wells Fargo
    8/3/2023$5.00 → $2.50Overweight → Equal-Weight
    Morgan Stanley
    3/23/2023$5.00 → $2.50Outperform → Market Perform
    TD Cowen
    2/27/2023$5.00 → $3.50Overweight → Neutral
    Piper Sandler
    1/4/2023$4.20Neutral → Buy
    BofA Securities
    9/7/2022$5.00Hold
    Truist
    4/14/2022$6.00Buy
    Guggenheim
    4/1/2022$5.00Neutral
    Credit Suisse
    More analyst ratings

    $AMWL
    SEC Filings

    View All

    SEC Form 10-Q filed by American Well Corporation

    10-Q - American Well Corp (0001393584) (Filer)

    8/5/25 4:10:20 PM ET
    $AMWL
    Real Estate

    American Well Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - American Well Corp (0001393584) (Filer)

    8/5/25 4:08:01 PM ET
    $AMWL
    Real Estate

    American Well Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - American Well Corp (0001393584) (Filer)

    6/17/25 4:57:19 PM ET
    $AMWL
    Real Estate

    $AMWL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amwell makes grant to new employees under inducement plan

    BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 76,198 shares of its Class A common stock to two new employees. The grants were offered as material inducement to the employees' employment with Amwell. The RSUs will vest as follows, subject to the applicable employee's continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date ("Initial Vesting Date"), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first

    8/8/25 4:05:00 PM ET
    $AMWL
    Real Estate

    Amwell® Announces Results for Second Quarter 2025

    BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30. The company's second quarter earnings report may be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/ve8zytc3/. A webcast replay will be available for approximately 90 days at investors.amwell.com. About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. W

    8/5/25 4:05:00 PM ET
    $AMWL
    Real Estate

    Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System ("MHS")

    BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading technology-enabled care platform provider, announced that as part of a Leidos-led partnership, it has been awarded an extension of its next-generation Digital First contract to power the digital transformation of the Military Health System (MHS), which serves approximately 9.6 million beneficiaries. Under the contract extension, Amwell will continue to provide its comprehensive technology-enabled care platform to power virtual care delivered by MHS providers. The platform for scheduled virtual visits has been successfully deployed, on time and on budget, across the global DOD enterprise and to the U.S. Military Entra

    8/5/25 8:30:31 AM ET
    $AMWL
    Real Estate

    $AMWL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice Chairman Schoenberg Roy was granted 25,000 shares, increasing direct ownership by 23% to 133,302 units (SEC Form 4)

    4 - American Well Corp (0001393584) (Issuer)

    8/14/25 4:33:43 PM ET
    $AMWL
    Real Estate

    Chairman, co-CEO Schoenberg Ido was granted 50,000 shares, increasing direct ownership by 78% to 114,250 units (SEC Form 4)

    4 - American Well Corp (0001393584) (Issuer)

    8/14/25 4:33:31 PM ET
    $AMWL
    Real Estate

    President, International Gotlib Phyllis sold $42,773 worth of shares (4,958 units at $8.63), decreasing direct ownership by 3% to 136,891 units (SEC Form 4)

    4 - American Well Corp (0001393584) (Issuer)

    7/1/25 4:35:20 PM ET
    $AMWL
    Real Estate

    $AMWL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Amwell upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Amwell from Equal Weight to Overweight and set a new price target of $15.00

    1/13/25 7:29:38 AM ET
    $AMWL
    Real Estate

    Amwell downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Amwell from Overweight to Equal-Weight and set a new price target of $2.50 from $5.00 previously

    8/3/23 6:19:10 AM ET
    $AMWL
    Real Estate

    Amwell downgraded by TD Cowen with a new price target

    TD Cowen downgraded Amwell from Outperform to Market Perform and set a new price target of $2.50 from $5.00 previously

    3/23/23 7:15:52 AM ET
    $AMWL
    Real Estate

    $AMWL
    Leadership Updates

    Live Leadership Updates

    View All

    Amwell announces new chief financial officer

    BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeeding Robert "Bob" Shepardson, who has been in the role since 2021. Hirschhorn will oversee Amwell's financial operations, enterprisewide optimization and capital allocation activities, and will play a meaningful leadership role in guiding the company's strategy to support its long-term growth objectives and enhance shareholder value.   Hirschhorn is a healthcare technology industry leader, with over three decades of experience in financial and strategic operations, having served in senior executiv

    10/15/24 4:30:00 PM ET
    $AMWL
    Real Estate

    Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors

    Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13. "Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell's path to profitability. Ricky's strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growth, while remaining committed to enabling our clients to achieve their goals. We are pleased to welcome Ricky to the team," said Ido Schoenberg, M.D., CEO and chairman, Amwell. Ms. Gol

    6/17/24 8:05:00 AM ET
    $AMWL
    Real Estate

    Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

    ALACHUA, Fla. and TAMPA, Fla., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce today the appointment of Mrs. Kathy Weiler to its Board of Directors, effective December 20, 2023. Weiler, a senior executive with 20+ years of experience and proven track record in driving strategic commercial initiatives, will serve on the Board's Governance, Nominating and Sustainability Committee, and the Quality, Compliance, and Portfolio Management Committee. "I am happy to welcome Kathy to the Board as Axogen is approaching an exciting inflection point in its journ

    12/26/23 4:15:00 PM ET
    $AMWL
    $AXGN
    Real Estate
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AMWL
    Financials

    Live finance-specific insights

    View All

    Amwell® Announces Results for Second Quarter 2025

    BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30. The company's second quarter earnings report may be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/ve8zytc3/. A webcast replay will be available for approximately 90 days at investors.amwell.com. About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. W

    8/5/25 4:05:00 PM ET
    $AMWL
    Real Estate

    Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences

    BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on Tuesday, Aug. 5. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell

    7/22/25 4:05:00 PM ET
    $AMWL
    Real Estate

    Amwell® Announces Results for First Quarter 2025

    BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. About Amwell Amwell offers payers and

    5/1/25 4:05:00 PM ET
    $AMWL
    Real Estate

    $AMWL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by American Well Corporation

    SC 13G/A - American Well Corp (0001393584) (Subject)

    11/12/24 4:43:25 PM ET
    $AMWL
    Real Estate

    SEC Form SC 13G filed by American Well Corporation

    SC 13G - American Well Corp (0001393584) (Subject)

    11/6/24 4:14:27 PM ET
    $AMWL
    Real Estate

    SEC Form SC 13G filed by American Well Corporation

    SC 13G - American Well Corp (0001393584) (Subject)

    11/4/24 11:53:44 AM ET
    $AMWL
    Real Estate